• 11-01-2021

DeepIntent Survey Reveals That Pharmaceutical Advertising Motivates Patients to Research Treatment and Medication Options

DeepIntent surveyed 1,244 U.S. patients in August 2021 about their attitudes toward pharmaceutical ads and whether they find them relevant.

In this article, Pharmaceutical Executive Magazine shares key takeaways from the survey revealing how advertising motivates patients to research their treatment and medication options. DeepIntent’s CEO Chris Paquette also shares the opportunities healthcare marketers can act on as a result of this research.

Read more here.

More News

Article
Guide HCPs from Awareness to Action with Sequential Messaging
5-6-2025
Pharmaceutical advertising is a critical part of the information landscape for today’s healthcare providers (HCPs). According to a study conducted by MAGNA Media Trials...
Read More
Article
What Pharma Marketers Are Saying About CTV This Upfront Season
5-1-2025
As upfront season kicks off, media buyers across industries are recalibrating their video strategies, determining both how much to spend and where to spend...
Read More
Article
The Future of Endemic Publishers and Programmatic
4-25-2025
In a vibrant session at AdLab 2025, a panel of industry leaders explored how endemic publishers are adapting to a rapidly evolving programmatic landscape....
Read More